FDA approves Zeposia as oral treatment for relapsing forms of multiple sclerosis March 27, 2020 No Comments
Velexbru approved in Japan for recurrent or refractory primary central nervous system lymphoma March 26, 2020 No Comments
Dupixent approved for additional indication of chronic rhinosinusitis with nasal polyp March 26, 2020 No Comments
Japanese approval of Tepmetko for advanced NSCLC with METex14 skipping alterations March 25, 2020 No Comments
FDA approves Ofev for chronic fibrosing interstitial lung diseases with a progressive phenotype March 10, 2020 No Comments
RSS